Infinity Pharmaceuticals Inc
XBI Holdings Finished Strong as Market Bounced Back on April 13
On April 13, 2016, the SPDR S&P Biotech ETF (XBI) gained 2.4% for the day. XBI outperformed the SPDR S&P 500 ETF (SPY), which gave a return of 1.1%.
AbbVie: The Benefits of Research and Development Collaboration
AbbVie and Alvine Pharmaceuticals have been collaborating since May 2013 to develop ALV003, a novel oral treatment for patients with celiac disease.